Journal article · 1997

Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer Patients: Clinical and Economic Considerations

Fausto de Lalla

Drugs, 53(5), 789–804 · Published 1 May 1997 · DOI 10.2165/00003495-199753050-00005

View at the publisherCite this paper

In brief

“Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer Patients: Clinical and Economic Considerations” is a 1997 journal article by Fausto de Lalla, published in Drugs. OpenAlex counts 30 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
30
Most cited in
2012 (1)
Field-weighted impact
2.12
References
103
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

de Lalla, F. (1997). Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer Patients: Clinical and Economic Considerations. Drugs, 53(5), 789–804. https://doi.org/10.2165/00003495-199753050-00005

MLA 9

de Lalla, Fausto. “Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer Patients: Clinical and Economic Considerations.” Drugs, vol. 53, no. 5, 1997, pp. 789–804. https://doi.org/10.2165/00003495-199753050-00005.

Chicago

de Lalla, Fausto. 1997. “Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer Patients: Clinical and Economic Considerations.” Drugs 53 (5): 789–804. https://doi.org/10.2165/00003495-199753050-00005.

Harvard

de Lalla, F. (1997) ‘Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer Patients: Clinical and Economic Considerations’, Drugs, 53(5), pp. 789–804. doi:10.2165/00003495-199753050-00005.

IEEE

F. de Lalla, “Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer Patients: Clinical and Economic Considerations,” Drugs, vol. 53, no. 5, pp. 789–804, 1997, doi: 10.2165/00003495-199753050-00005.

BibTeX

@article{delalla1997antibiotic,
  title     = {{Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer Patients: Clinical and Economic Considerations}},
  author    = {de Lalla, Fausto},
  journal   = {Drugs},
  year      = {1997},
  volume    = {53},
  number    = {5},
  pages     = {789--804},
  doi       = {10.2165/00003495-199753050-00005},
  url       = {https://doi.org/10.2165/00003495-199753050-00005}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201211
202011
202111

Its field-weighted citation impact is 2.12: it has been cited 2.12 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections

  • febrile neutropenia
  • cancer patients
  • antibiotic therapy
  • empirical treatment
  • Gram-positive bacterial infections
  • antibiotic resistance
  • methicillin-resistant staphylococci
  • glycopeptides

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

de Lalla, F. (1997). Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer Patients: Clinical and Economic Considerations. Drugs, 53(5), 789–804. https://doi.org/10.2165/00003495-199753050-00005

How many times has this paper been cited?

30 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Fausto de Lalla.

What is the DOI of this paper?

10.2165/00003495-199753050-00005, permanently at https://doi.org/10.2165/00003495-199753050-00005. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.